This week on the Kingscrowd Podcast, Brian Belley, Léa Bouhelier-Gautreau, and Teddy Lyons break down where equity crowdfunding dollars are flowing across the U.S. by city and state over the past 18 months. Expect familiar hubs like Boston, San Francisco, and Los Angeles, but also surprises like Las Vegas and Denver/Boulder.
Teddy then reviews Foment Bio, a biotech startup developing non-viral gene therapies targeting heart and kidney disease — with an animal-first commercialization pathway that could generate revenue sooner through licensing and partnerships.
Topics
Chart of the Week: Capital raised by city & state (18-month window)
Hotspots: Bay Area, Boston/Cambridge, Florida, Chicago, Texas, Colorado
Surprises: Las Vegas emerges as a top dot
Deal Review: Foment Bio (FB-101, FB-201), plasmid-based gene therapy, animal-first licensing